Effect of Ergon IASTM technique in treatment of chronic low back pain

Effectiveness of Ergon Technique with Neuromuscular Electrical Stimulation in Addition to Routine Physical Therapy on Pain and Functional Mobility in Patients with Non Specific Chronic Low Back Pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201101049222N1

Enrollment

Registered

2020-11-27

Start date

2020-03-09

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Specific Chronic Low Back Pain. Low back pain

Interventions

Intervention 1: Intervention group: ERGON + EMS +RPT. Progression of ERGON Technique from basic to advance using multiple strokes on lower back especially paraspinal muscles, multifidus and transverse

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Diagnosed patients of chronic low back pain (CLBP) duration 3 months or greater Both adult males and females; 18 - 60 years of age Body mass index (BMI) less than 30

Exclusion criteria

Exclusion criteria: Positive nerve root tension signs, signs of progressive or persistent neurological deficit. Suffered from any spinal tumor or infection, spinal fracture Contraindications to Ergon Technique and neuromuscular electrical stimulation (NMES) (e.g. skin allergy/wound). Have severe cardiovascular or pulmonary problems Fibromyalgia, cauda equina syndrome, previous spine surgery or musculoskeletal injuries of the lower limbs, pregnancy or plans to become pregnant. Systemic disease (autoimmune, infectious, vascular, endocrine, metabolic or neoplasic disease) Previous experience with myofascial therapy or a history of rehabilitation treatment for back pain within the preceding 1 month.

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: At baseline (before intervention), and at end of treatment (4 weeks). Method of measurement: Numeric pain rating scale (NPRS). The NPRS measures pain intensity on an 11-point scale from 0 (no pain) to 10 (maximum pain). We used the ‘‘triple NPRS’’ in which the subject is asked to respond to three questions:(1) the intensity of current pain; (2) the best pain intensity in the past 24 h; and (3) the worst pain intensity in the past 24 h. The mean of these sub-scores was reported as the subject’s NPRS score.;Functional mobility. Timepoint: At baseline (before intervention), and at end of treatment (4 weeks). Method of measurement: Modified Oswestry disability questionnaire (MODQ). The MODQ is a self-reported measure of functional disability consisting of 10 questions about various activities related to back pain. Each question has 6 possible responses ranging from 0 to 5, with a total possible maximum score of 50.The total MODQ score is multiplied by 2 to get a percentage score, with higher percentages indicating greater levels of self-reported disability.	—

Measure

Time frame

Pain. Timepoint: At baseline (before intervention), and at end of treatment (4 weeks). Method of measurement: Numeric pain rating scale (NPRS). The NPRS measures pain intensity on an 11-point scale from 0 (no pain) to 10 (maximum pain). We used the ‘‘triple NPRS’’ in which the subject is asked to respond to three questions:(1) the intensity of current pain; (2) the best pain intensity in the past 24 h; and (3) the worst pain intensity in the past 24 h. The mean of these sub-scores was reported as the subject’s NPRS score.;Functional mobility. Timepoint: At baseline (before intervention), and at end of treatment (4 weeks). Method of measurement: Modified Oswestry disability questionnaire (MODQ). The MODQ is a self-reported measure of functional disability consisting of 10 questions about various activities related to back pain. Each question has 6 possible responses ranging from 0 to 5, with a total possible maximum score of 50.The total MODQ score is multiplied by 2 to get a percentage score, with higher percentages indicating greater levels of self-reported disability.

—

Secondary

Measure	Time frame
Fear Avoidance. Timepoint: At baseline (before intervention) and at end of treatment (4 weeks). Method of measurement: The Fear Avoidance-Behavior Questionnaire (FABQ) is a self-reported questionnaire consisting of a total of 16 items, divided into two subscales: physical activity (5 items) and work (11 items). Not all items are calculated toward the final score (i.e. item 1 in the physical activity scale, and items 8, 12, 14 and 16 in the work scale do not count). The total possible maximum FABQ score is 66, with higher scores indicating greater levels of fear avoidance.	—

Measure

Time frame

Fear Avoidance. Timepoint: At baseline (before intervention) and at end of treatment (4 weeks). Method of measurement: The Fear Avoidance-Behavior Questionnaire (FABQ) is a self-reported questionnaire consisting of a total of 16 items, divided into two subscales: physical activity (5 items) and work (11 items). Not all items are calculated toward the final score (i.e. item 1 in the physical activity scale, and items 8, 12, 14 and 16 in the work scale do not count). The total possible maximum FABQ score is 66, with higher scores indicating greater levels of fear avoidance.

—

Countries

Pakistan

Contacts

Public ContactMuhammad Haider Ullah Khan

The University of Lahore

haiderullah@live.comSheikhupura

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026